Sanofi, Huons Genexine with extended innovative pharmaceutical company certificate by 2020

Published: 2017-11-28 16:14:17

Updated: 2017-11-28 16:14:17

Sanofi Aventis Korea, Genexine and Huons, the 3 companies’ innovative pharmaceutical company certificate will be extended to 2020. SK Chemicals, which recently had a corporate spin-off, was approved with the certificate.

The Ministry of Health and Welfare(Minister Neung-Hoo Park) announced the ministry reviewed and decided agendas related to extension of innovative pharmaceutical company certi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.